US Patent Issued to Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences on March 3 for "Pancreatic endocrine progenitor cells and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,611, issued on March 3, was assigned to Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences.

"Pancreatic endocrine progenitor cells and use thereof" was invented by Yi Zeng (Shanghai) and Daisong Wang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are endocrine progenitor cells and organoids derived from adult islets in vitro, as well as methods for making and using the same. The compositions are useful for treating or preventing diabetes, other diseases or disorders characterized by impaired islet function, and symptoms thereof."

The patent was filed on Sept. 17, 2020, under Application No. 17/761...